NYSE:NUS

Stock Analysis Report

Executive Summary

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide.

Snowflake

Fundamentals

Established dividend payer with adequate balance sheet.

Risks

  • Nu Skin Enterprises has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Nu Skin Enterprises's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.3%

NYSE:NUS

9.9%

US Personal Products

0.9%

US Market


1 Year Return

-49.6%

NYSE:NUS

17.3%

US Personal Products

0.3%

US Market

NUS underperformed the Personal Products industry which returned 8.1% over the past year.

NUS underperformed the Market in United States of America which returned -0.5% over the past year.


Share holder returns

NUSIndustryMarket
7 Day0.3%9.9%0.9%
30 Day-1.6%2.5%-1.9%
90 Day-21.8%8.4%1.6%
1 Year-48.4%-49.6%19.0%17.3%2.6%0.3%
3 Year-25.7%-30.8%38.9%31.7%41.0%31.8%
5 Year-5.7%-18.3%79.7%61.5%55.2%38.0%

Price Volatility Vs. Market

How volatile is Nu Skin Enterprises's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nu Skin Enterprises undervalued based on future cash flows and its price relative to the stock market?

35%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Nu Skin Enterprises's share price is below the future cash flow value, and at a moderate discount (> 20%).

Nu Skin Enterprises's share price is below the future cash flow value, but not at a substantial discount (< 40%).


Price Based on Earnings

Nu Skin Enterprises is good value based on earnings compared to the US Personal Products industry average.

Nu Skin Enterprises is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Nu Skin Enterprises is poor value based on expected growth next year.


Price Based on Value of Assets

Nu Skin Enterprises is good value based on assets compared to the US Personal Products industry average.


Next Steps

Future Growth

How is Nu Skin Enterprises expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

10.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Nu Skin Enterprises's revenue is expected to grow by 0.9% yearly, however this is not considered high growth (20% yearly).

Nu Skin Enterprises's earnings are expected to grow by 10.4% yearly, however this is not considered high growth (20% yearly).

Nu Skin Enterprises's revenue growth is positive but not above the United States of America market average.

Nu Skin Enterprises's earnings growth is positive but not above the United States of America market average.

Nu Skin Enterprises's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Nu Skin Enterprises is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has Nu Skin Enterprises performed over the past 5 years?

-12.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Nu Skin Enterprises's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.

Nu Skin Enterprises's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Nu Skin Enterprises's 1-year earnings growth is negative, it can't be compared to the US Personal Products industry average.


Return on Equity

Nu Skin Enterprises has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Nu Skin Enterprises used its assets less efficiently than the US Personal Products industry average last year based on Return on Assets.


Return on Capital Employed

Nu Skin Enterprises has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Nu Skin Enterprises's financial position?


Financial Position Analysis

Nu Skin Enterprises is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Nu Skin Enterprises's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Nu Skin Enterprises's level of debt (48.9%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (23.7% vs 48.9% today).

Debt is well covered by operating cash flow (55.2%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 14.7x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.9x debt.


Next Steps

Dividend

What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?

3.65%

Expected Dividend Yield


Upcoming Dividend Payment

Purchase Nu Skin Enterprises before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield and Payments Analysis

Nu Skin Enterprises's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.49%).

Nu Skin Enterprises's dividend is below the markets top 25% of dividend payers in United States of America (3.84%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are covered by earnings (1.5x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be well covered by earnings (2.3x coverage).


Next Steps

Management

What is the CEO of Nu Skin Enterprises's salary, the management and board of directors tenure and is there insider trading?

8.0yrs

Average management tenure


CEO

Ritch Wood (53yo)

2.4yrs

Tenure

US$6,065,610

Compensation

Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to Mar ...


CEO Compensation Analysis

Ritch's remuneration is higher than average for companies of similar size in United States of America.

Ritch's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.


Management Age and Tenure

8.0yrs

Average Tenure

55yo

Average Age

The average tenure for the Nu Skin Enterprises management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

8.4yrs

Average Tenure

66yo

Average Age

The tenure for the Nu Skin Enterprises board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Blake Roney (60yo)

    • Tenure: 35.6yrs
    • Compensation: US$621.69k
  • Steve Lund (66yo)

    Executive Chairman of the Board

    • Tenure: 7.3yrs
    • Compensation: US$1.26m
  • Sandie Tillotson (62yo)

    • Tenure: 23.6yrs
    • Compensation: US$1.06m
  • Ritch Wood (53yo)

    CEO & Director

    • Tenure: 2.4yrs
    • Compensation: US$6.07m
  • Matt Dorny (55yo)

    Executive VP

    • Tenure: 16.6yrs
    • Compensation: US$1.94m
  • Joe Chang (66yo)

    Executive VP of Product Development & Chief Scientific Officer

    • Tenure: 13.5yrs
    • Compensation: US$2.33m
  • Ryan Napierski (45yo)

    President

    • Tenure: 2.4yrs
    • Compensation: US$3.47m
  • Mark Lawrence (49yo)

    Executive VP & CFO

    • Tenure: 2.4yrs
    • Compensation: US$2.07m
  • Vince Perfetti

    Chief Transformation Officer & Senior VP of Technology

    • Tenure: 0.3yrs
  • James Thomas (41yo)

    Chief Accounting Officer

    • Tenure: 0.0yrs

Board Members

  • Steve Lund (66yo)

    Executive Chairman of the Board

    • Tenure: 7.3yrs
    • Compensation: US$1.26m
  • Edwina Woodbury (67yo)

    Director

    • Tenure: 4.2yrs
    • Compensation: US$298.44k
  • Andy Lipman (67yo)

    Independent Director

    • Tenure: 20.3yrs
    • Compensation: US$298.94k
  • Dan Campbell (64yo)

    Lead Independent Director

    • Tenure: 0.0yrs
    • Compensation: US$300.44k
  • Ritch Wood (53yo)

    CEO & Director

    • Tenure: 2.4yrs
    • Compensation: US$6.07m
  • Lars Bohlin

    Member of Anti-Aging Scientific Advisory Board

    • Tenure: 0.0yrs
  • Thomas Pisano (74yo)

    Independent Director

    • Tenure: 11.2yrs
    • Compensation: US$298.44k
  • Zoe Draelos

    Member of the Anti-Aging Scientific Advisory Board

    • Tenure: 9.6yrs
  • Tomas Prolla

    Member of Anti-aging Scientific Advisory Board

    • Tenure: 9.8yrs
  • Simon Shen (39yo)

    Director

    • Tenure: 3.1yrs
    • Compensation: US$254.94k

Company Information

Nu Skin Enterprises, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nu Skin Enterprises, Inc.
  • Ticker: NUS
  • Exchange: NYSE
  • Founded: 1984
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$2.241b
  • Shares outstanding: 55.55m
  • Website: https://www.nuskin.com

Number of Employees


Location

  • Nu Skin Enterprises, Inc.
  • 75 West Center Street
  • Provo
  • Utah
  • 84601
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NUSNYSE (New York Stock Exchange)YesClass A Common StockUSUSDNov 1996
NUSDB (Deutsche Boerse AG)YesClass A Common StockDEEURNov 1996

Biography

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, in ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/19 23:40
End of Day Share Price2019/08/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.